|
|||||
|
|

Eyewear retailer Warby Parker (NYSE:WRBY) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 13.9% year on year to $214.5 million. The company’s full-year revenue guidance of $884 million at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.08 per share was in line with analysts’ consensus estimates.
Is now the time to buy WRBY? Find out in our full research report (it’s free).
Warby Parker’s second quarter saw revenue growth driven by continued retail expansion, product innovation, and a disciplined approach to cost management, even as the market responded negatively to the results. Management credited the increase in active customers and retail channel strength, with co-CEO David Gilboa highlighting “disciplined execution and ability to adapt in a dynamic environment,” as the team navigated tariff impacts and optimized its store and digital presence. Despite a challenging April, the company reported sequential improvement through the quarter, citing success in both new store openings and the ramp-up of insurance customers as important factors supporting overall sales momentum.
Looking ahead, Warby Parker’s raised full-year outlook is underpinned by ongoing investments in store growth, digital experience enhancements, and new partnerships—most notably its collaboration with Google for AI-powered intelligent eyewear. Management sees opportunities to leverage AI for personalized digital tools and to reallocate resources from the soon-to-end home try-on program into customer acquisition. CFO Steve Miller emphasized that “continued SG&A leverage and supply chain flexibility” will support margin expansion, while management pointed to a strong pipeline of new stores and insurance partnerships as key tailwinds for sustained growth.
Management attributed the quarter’s growth to higher customer acquisition, increased retail productivity, and the rollout of new digital and product initiatives, alongside ongoing cost controls and selective price increases.
Management expects growth to be driven by retail expansion, digital innovation, and continued insurance penetration, while maintaining cost discipline to support margin gains.
In the coming quarters, the StockStory team will watch (1) the pace of new store openings and performance of Target shop-in-shops, (2) adoption and conversion rates for AI-powered digital tools like Advisor, and (3) continued growth in insurance customer penetration and the integration of new insurance partners. Execution on the Google AI eyewear partnership and effective cost management will also be critical signposts for Warby Parker’s trajectory.
Warby Parker currently trades at $23.11, down from $24.30 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-16 | |
| Oct-08 | |
| Oct-07 | |
| Oct-05 | |
| Sep-23 | |
| Sep-22 | |
| Sep-16 | |
| Sep-11 | |
| Sep-05 | |
| Aug-28 | |
| Aug-27 | |
| Aug-27 | |
| Aug-14 | |
| Aug-14 | |
| Aug-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite